Judge Sanctions Roxane In Asacol Patent Suit

Law360, New York (January 31, 2011, 8:11 PM EST) -- A federal judge has ruled that Roxane Laboratories Inc. must pay some of the expert and attorneys' fees for the plaintiffs in a patent dispute over inflammatory bowel drug Asacol as punishment for concealing a batch of its generic version.

Magistrate Judge Tonianne Bongiovanni of the U.S. District Court for the District of New Jersey on Friday granted a motion by Medeva Pharma Suisse AG and Warner Chilcott Pharmaceuticals Inc. to impose sanctions for Roxane's concealment, but denied the plaintiffs' motion to impose sanctions for Roxane's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.